Economic evaluation of pharmacogenetic tests in patients subjected to renal transplantation: a review of literature
Renal transplantation is the treatment of choice for the patients with end-stage renal failure. Genetic factors, among others, can influence variability in response to immunosuppressive drugs. Nowadays, due to restrictive health resources, the question arises whether routine pharmacogenetic analyses...
Main Authors: | Nemanja Rancic, Viktorija Dragojevic-Simic, Neven Vavić, Aleksandra Kovacevic, Zoran Segrt, Natasa Djordjevic |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2016-08-01
|
Series: | Frontiers in Public Health |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fpubh.2016.00189/full |
Similar Items
-
The relationship between tacrolimus concentration-dose ratio and genetic polymorphism in patients subjected to renal transplantation
by: Rančić Nemanja, et al.
Published: (2018-01-01) -
Tacrolimus concentration/dose ratio as a therapeutic drug monitoring strategy: The influence of gender and comedication
by: Rančić Nemanja, et al.
Published: (2015-01-01) -
Pharmacogenetics and drug-induced nephrotoxicity in renal transplant recipients
by: Sepideh Zununi Vahed, et al.
Published: (2015-02-01) -
PHARMACOGENETICS – THE FUTURE OF THE DRUG THERAPY
by: Slobodan Jankovic, et al.
Published: (2007-10-01) -
Importance of Pharmacogenetics and Drug–Drug Interactions in a Kidney Transplanted Patient
by: Julia Concha, et al.
Published: (2023-07-01)